NIRAVAM Drug Patent Profile
✉ Email this page to a colleague
When do Niravam patents expire, and what generic alternatives are available?
Niravam is a drug marketed by Ucb Inc and is included in one NDA.
The generic ingredient in NIRAVAM is alprazolam. There are fifteen drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the alprazolam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Niravam
A generic version of NIRAVAM was approved as alprazolam by NOVITIUM PHARMA on October 19th, 1993.
Summary for NIRAVAM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 53 |
Clinical Trials: | 3 |
Patent Applications: | 4,544 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for NIRAVAM |
What excipients (inactive ingredients) are in NIRAVAM? | NIRAVAM excipients list |
DailyMed Link: | NIRAVAM at DailyMed |
Recent Clinical Trials for NIRAVAM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Actavis Inc. | Phase 1 |
UCB Pharma | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for NIRAVAM
Paragraph IV (Patent) Challenges for NIRAVAM
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
NIRAVAM | Orally Disintegrating Tablets | alprazolam | 0.25 mg, 0.5 mg, 1 mg and 2 mg | 021726 | 1 | 2005-12-27 |
US Patents and Regulatory Information for NIRAVAM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ucb Inc | NIRAVAM | alprazolam | TABLET, ORALLY DISINTEGRATING;ORAL | 021726-001 | Jan 19, 2005 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ucb Inc | NIRAVAM | alprazolam | TABLET, ORALLY DISINTEGRATING;ORAL | 021726-004 | Jan 19, 2005 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ucb Inc | NIRAVAM | alprazolam | TABLET, ORALLY DISINTEGRATING;ORAL | 021726-002 | Jan 19, 2005 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ucb Inc | NIRAVAM | alprazolam | TABLET, ORALLY DISINTEGRATING;ORAL | 021726-003 | Jan 19, 2005 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NIRAVAM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ucb Inc | NIRAVAM | alprazolam | TABLET, ORALLY DISINTEGRATING;ORAL | 021726-003 | Jan 19, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
Ucb Inc | NIRAVAM | alprazolam | TABLET, ORALLY DISINTEGRATING;ORAL | 021726-002 | Jan 19, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
Ucb Inc | NIRAVAM | alprazolam | TABLET, ORALLY DISINTEGRATING;ORAL | 021726-001 | Jan 19, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
Ucb Inc | NIRAVAM | alprazolam | TABLET, ORALLY DISINTEGRATING;ORAL | 021726-002 | Jan 19, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
Ucb Inc | NIRAVAM | alprazolam | TABLET, ORALLY DISINTEGRATING;ORAL | 021726-003 | Jan 19, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
Ucb Inc | NIRAVAM | alprazolam | TABLET, ORALLY DISINTEGRATING;ORAL | 021726-004 | Jan 19, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
Ucb Inc | NIRAVAM | alprazolam | TABLET, ORALLY DISINTEGRATING;ORAL | 021726-001 | Jan 19, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NIRAVAM
See the table below for patents covering NIRAVAM around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2284663 | DISSOLUTION RAPIDE DE FORME POSOLOGIQUE DE BONNE TENUE (RAPIDLY DISSOLVING ROBUST DOSAGE FORM) | ⤷ Try a Trial |
Portugal | 2147669 | ⤷ Try a Trial | |
European Patent Office | 2147669 | Formule de dosage robuste à dissolution rapide (Rapidly dissolving robust dosage form) | ⤷ Try a Trial |
European Patent Office | 2266538 | Formule de dosage robuste à dissolution rapide (Rapidly dissolving robust dosage form) | ⤷ Try a Trial |
Australia | 726336 | ⤷ Try a Trial | |
Denmark | 2147669 | ⤷ Try a Trial | |
Hong Kong | 1137654 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |